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ABSTRACT
Difference in cellular response due to secondary bacterial
messenger in Oasl1 KO mouse
YuneSahng Hwang
Department of Integrated OMICS for Biomedical Science
The Graduate School
Yonsei University
  A role of interferons during bacterial or viral infection has always been a 
subject of much interest. Investigations led by researchers since early 1900's 
led to great discoveries including discovery of JAK-STAT pathway and 
different types of IFNs.. However, we still do not fully understand how IFNs 
communicate among themselves. Moreover, the role of type I IFNs during 
bacterial infection leaves much room for discussion.
  c-di-GMP and c-di-AMP are bacterial secondary messengers that are 
known to initiate bio-film formation and mediate proliferation of bacteria 
inside cytosol. PRRs recognize these molecules and initiate anti-bacterial 
defense against them. Recently, a group of researchers reported that these 
nucleotides can induce type I IFNs production in STING dependent manner.  
  In this study, we used Oasl1 transgenic mice, which are known to produce 
increased level of type I IFNs in response to pathogenic invasion in order to 
delineate the significance of production of type I IFNs during bacterial 
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infection. We sought to mimic this condition by transfecting BMDMs from 
Oasl1 KO mice with bacterial secondary messengers.
  We discovered increased type I IFNs mRNA expression in KO mice 
compared to WT mice. This led to increased mRNA transcription of various 
cytokines in KO mice, notably IL-10 and CXCL10. On the other hand, mRNA 
expression of IL-1β increased in WT mice. Interestingly, TNFα that are 
known to be regulated by IL-10, did not differ either in mRNA level measured 
by qPCR analysis or protein level measured by ELISA suggesting NF-κB 
pathway is not altered in Oasl1 KO mice during bacterial infection. Increase in 
IL-10 level in KO mice may lead to inhibition of anti-bacterial peptides 
secreted by IFNγ induced macrophages. This indicate that increased type I 
IFN production may be harmful to the host during infection because bacteria 
cannot be suppressed properly.
  Higher expression of IL-1β mRNA in WT compared to that of KO may be 
explained by increased IL-10 level in KO mice. Yet, protein levels and 
mechanism for regulation should be explored as there are two reported 
pathways for regulation. CXCL10 is mainly produced by IFNγ induced 
macrophages; thus, increase in mRNA expression in KO mice should be 
investigated.
  Since c-di-GMP and c-di-AMP work along with other factors in bacteria, 
BMDMs from Oasl1 WT and KO were treated with BCG. While mRNA 
expression of IL-10 showed significant difference between WT and KO, 
protein level of cells treated with BCG did not show much difference. Further 
investigation regarding pathology of BCG should be conducted to better 
understand this phenomenon.
  Our study indicates that increase in production of type I IFNs can lead to 
worsening of bacterial infection and patients with autoimmune disease may  be 
more susceptible to invasion by certain types of bacteria.
11. INTRODUCTION
Since their discovery by Isaacs and Lindenmann (Issacs and Lindenmann, 1957),
interferons(IFNs) have revealed to be more potent molecules than it was originally
thought. Not only do they participate in innate immunity, they also serve
important roles during adaptive immune responses. During early stages of
infection, recognition of pathogen-associated molecular patterns (PAMPs) by
pattern-recognition receptors (PRRs) leads to activation of various pathways which
lead to production of IFNs. As a result, various Interferon stimulated genes (ISGs)
are induced and they can enhance or suppress responses depending on the
situation (Ivashkiv & Donlin et al., 2014).
Based on the type of receptors they bind to, IFNs are further categorized into
three major groups: type I, II, and III(González -Navajas, Lee, David, Raz,
2012). Type I group consist of interferon-α and interferon-β, that are major
contributors to immune responses during viral infection. They can activate
JAK-STAT pathway through binding to Tyk receptor that can autophosphorylate,
followed by phosphorylation of Signal Transducer and Activator of Transcription
(STAT). Subsequently, STATs are imported to nucleus and induce production of
ISGs. Later, they are exported back to the cytoplasm and signal subsidizes
(Schidnler, Levy, and Decker et al., 2007). STATs are also negatively regulated by
suppressor of cytokine signaling (SOCS) and protein inhibitor of activated STAT
(PIAS) family (Shuai and Liu et al., 2003).
Production of ISGs by type I IFNs is essential for anti-viral responses though
efficacy of each differs significantly. While MX1, PKR and OAS1, that were
discovered early, are very strong inhibitors, other ISGs, that were discovered later,
are not so potent. This gradient in inhibition may be attributed to immune
system's attempt to regulate immune activity as too much inhibition may actually
2hurt host.
Type II group consist of interferon-γ, which has been associated with
anti-bacterial responses. IFNγ is one of most potent stimulators of macrophages
and this leads to induction of anti-microbial and antitumor function (Schroder,
Hertzog, Ravasi, and Hume et al., 2003). The role of type III IFNs is little vague
since their discovery is relatively modern compared to that of other IFNs;
however, their importance was highlighted during certain virus infections (Vilcek,
2003).
It has recently come to attention that c-di-GMP and c-di-AMP which regulate
bacterial film formation and proliferation can illicit immune responses including
increased expression of interferon-β. Cyclic-dimer (3’->5’) GMP(c-di-GMP) was
reported in 1987 as an activator of cellulose synthase (Ross, 1987). Since then,
further researches on these particular nucleotides revealed other functions such as
regulation of a cell cycle, motility, and intra-cellular proliferation (D’Argenio and
Miller, 2004). Structure of c-di-GMP contains two guanine bases that are linked
by ribose and phosphate. Along with c-di-GMP, c-di-AMP is also a bacterial
secondary messenger that is known to serve similar functions in bacteria. One
unusual aspect of these nucleotides is that only bacteria seem to utilize them
(Hengge et al., 2009). Thus, they are becoming promising targets for clinical
researches. One of the best understood pathways of c-di-GMP and c-di-AMP
involves STING(Stimulator of interferon genes), TBK1(TANK-binding kinase 1),
and IRF3(interferon regulatory factor 3), where STING recognizes these
nucleotides and activates TBK-1 and IRF3. Dimeric form of phosphorylated IRF3
then immigrates to nucleus in which it acts as a regulatory factor that promotes
type I interferon production (McWhirter, 2009).
While c-di-GMP and AMP are produced in most bacterial species, Listeria
Monocytogens and Mycobacteria Tuberculosis (MTB) are among the most well
known species that utilize these molecules. MTB has been a major threat to
3global community for more than decades and about 1.5 million people die every
year because of various complications associated with it. Emergence of new
strains of bacteria that are resistant to antibiotics compound the problem as
doctors are faced with assigning more potent drugs that may be more invasive to
patients' bodies (Da Silva and Palomino et al. 2011). In developing countries where
MTB infection is prevalent, assigning other types of drugs may prove to be
difficult as they do not have wide access to antibiotics. Prevalence and difficulty
in treating MTB partially rise from its ability to evade host immune response by
laying dormant for more than decades. Recent report by Hong and his colleagues
revealed how c-di-GMP mediates tuberculosis dormancy and pathogenesis (Hong
et al., 2013). Furthermore, type I IFNs and type II IFNs are known to serve
different roles during the infection (Teles et al., 2013).
Bacillus Calmette-Guerin (BCG) is a single kind of vaccine against
mycobacterial species and it is attenuated version of bovine tubercle bacillus (Fine
and Rodrigues et al., 1990). It harbors Rv1354c and Rv1357c, that are c-di-GMP
signaling proteins; however, there exists a disruption in Rv1357c by transposon
insertion that results in attenuation of the bacteria by macrophages (Tao and
ZhengGuo et al., 2012). Furthermore, BCG lacks type VII secretion system ESX-1,
that prevents BCG from activating innate immune signaling in macrophages
(Wong and Jacobs et al., 2011).
In this study, we plan to focus on the role of type I interferon that is produced
in response to intra-cellular delivery of c-di-GMP and c-di-AMP. Since various
bacterial species utilize these molecules for proliferation, we believe that we can
mimic bacterial invasion of immune cells by delivering them inside cytosol through
transfection. Our aim is to understand what kind of role type I IFN serves during
infection with bacteria species that utilize these molecules. In order to understand
underlying mechanism clearly, we will use genetically modified Oasl1 knock-out
mouse.
4As a member of 2’-5’-oligoadenylate synthetase(OAS) family, Oasl1 is
characterized by OAS domain and two ubiquitin-like domains. OAS is well-known
for activation of RNase L by producing 2’-5’ oligoadenylate which result in
cleavage of all RNA in cell. On the other hand, role of Oasl1 had not been clearly
stated until recently. Previously, we reported that Oasl1 negatively regulates
production of type I interferon by binding to 5’-UTR region of IRF7 which is
well-known regulator of type I interferon production (Lee and Kim, 2013).
Negative regulation of type I IFNs by Oasl1 is also known to allow chronic virus
infection (Lee, Park, Jeon, Kim, and Ha et al., 2013). However, we do not know
how Oasl1 KO mice reacts to bacterial invasion.
By using BMDMs from Oasl1 KO mice and treating them with bacterial
secondary messengers, we hope to observe whether expression of type I IFNs are
different from that of KO. If so, we will observe how type I IFNs affect immune
responses during bacterial infection. Since Oasl1 KO mice are designed to produce
increased amount of type I IFNs in IRF7 dependent manner, we can observe
interferon dependent changes in less invasive manner without affecting other
important pathways such as NF-κB pathway.
52. MATERIALS AND METHODS
2.1. Cell culture and Bone marrow isolation
Oasl1 WT and KO mice were maintained in Sp*ecific Pathogen-free(SPF) room
at Yonsei Laboratory Animal Research Center. 8 to 12week old mice were
sacrificed by cervical dislocation method. Femurs and tibias were isolated and
washed with 75% EtOH. Bone marrows inside bones were isolated with DPBS +
0.05% EDTA, using 10ml syringes. They were then centrifuged at 1800rpm for
3min. at 4℃. Supernatants were thrown out and pellet were washed with 1ml
TDW for hemolysis and 1ml 2x DPBS was added to restore osmolarity. Bone
marrows were centrfuged again at the same condition, followed by discarding of
supernatants. Finally, pellets were suspended in Bone marrow Macrophage
conditioned media (BMMCM). For each mouse, 4 plates of 100pi petrish dishes
with 10ml media were used for culture. BMDMs from C57BL6/J and Oasl1[-/-]
were cultured in basic medium (DMEM (HyClone) supplemented with 10% FBS
(HyClone), 20% (v/v) supernata,mnt of L929 cell line and 50 U/ml penicillin and
50 ug/ml streptomycin. Cells were transfected with following otherwise noted:
c-di-GMP and c-di-AMP(5uM) by Lipofectamine 2000(Invitrogen, Carlsbad, CA)
according to manufacturer’s protocol. Inhibition assay was performed using Mouse
IFN-alpha Antibody clone (RMMA-1) at 25ng/ml
62.2 RNA Isolation
Total RNA from cells was isolated with TRIzol (Invitrogen). Chlroroform of
one-fifth volume of TRIzol was then added. Samples were vortexed briefly and
incubated in 4℃ for two minutes. They were then centrifuged at 13.2K for
15min., followed by transfer of clear phase into other tube using piepette. About
180ul of the phase was transferred and the same amount of isopropanol was added
to each tube. They were then mixed by inverting with hands and left for
incubation in ice for ten minutes. After incubation, samples were vortexed at
13.2K for ten minutes. Supernatants in samples were removed first by inverting
and then spin-down, followed by pipetting. 500ul of 75% Ethanol(25% DEPC-DW)
was added to each tube and samples were again centrifuged at 10K for 5minute.
After centrifugation, supernatants were thrown out by following protocol from
previous wash with isopropanol. Tube caps opened for air drying of samples for
7minutes. After time had passed, caps were closed and 13.5ul of DEPC-DW was
added to each tube.
72.3 cDNA generation and qPCR
Isolated RNAs were measured using Nano-drop machine for assessment of
purity and calculation of amount produced. 11.2ul sample was added along with
0.5ul oligoDT and 1ul dNTP into 8 well PCR tube. Samples were then incubated
in 65℃ for 5 minutes. 4ul of 5xFirst Strand Buffer, 2ul DTT, 1ul RNasin, and
0.3ul SuperScript II were added to each well. The reaction was carried-out under
'RT' protocol using Bio-Rad PCR machine.
With gene specific primers qPCR was used to measure individual gene expression
that is presented as ratio over house-keeping gene GAPDH. qPCR data in each
figure was reproduced with n>3 with two-tailed test.
2.4 Western Blot Analysis
For immunoblot analysis, cells were lysed with RIPA buffer [150mM Nacl, 1%
NP-40, 0.5% Sodium deoxycholate, 0.1% SDS, 0.05M Tris-Cl(pH 7.5)] with
protease inhibitor cocktail (Roche), followed by centrifugation at 17,000g for 10min.
at 4 ℃ for removal of pellet. Amount of proteins presiding in each samples were
measured with BCA assay by using TECAN. They were then mixed with 5x SDS
loading dye. Equal amounts of proteins were loaded into 10% acryl-amide gel and
transferred to the nitrocellose membranes(GE Healthcare). Membranes were
blocked with Tris-Buffered saline containing 0.1% Tween 20 (TBST) and 5%
skim milk (BD) for an hour. They were incubated overnight with specific
antibodies in 4 ℃ cold chamber. After overnight incubation, each membrane was
washed with TBST 3 times with 10 minute interval and signals were developed
with Amersham ECL reagents using ImageQuant LAS 4000 system (GE
Healthcare).
82.5 Enzyme-Linked Immunoabsorbent Assay
Both IL-1β and TNFα in BMDM culture supernatants were measured by
enzyme linked immunoabsorbent Assay. 96 wells were coated with antibodies
specific for each proteins that are diluted in coating buffer(100υl/well) provided the
manufacturer. Plates were incubated overnight at 4℃ and were subsequently
washed with washing buffer and were blocked with Diluent A(300υl/well). After
an hour, plates were washed again and culture supernatants were added to each
well (100υl/well). Two hours later, detection antibodies diluted in Diluent A(100υ
l/well) were added to each well after washing. Avidin-HRP diluted with Diluent
A(100υl/well) was added to each well after an hour, preceded by washing. Finally,
plates were washed(300υl/well) with 1min. interval for total of five times.
Substrate D(100υl/well) was added for development and stop solution(H2SO4) was
added to each well(100/well) when standards were developed in dose dependent
manner. Optical Density (OD) was measured at 450nM.
2.6 BCG infection of Oasl1 WT and KO BMMs
After 6days incubation in BMDM complete media, both types of cells were
seeded at the density of 8x10^5/well(12well) and incubated overnight. They were
then treated with or without poly I:C(10ug/ml) for 6hrs. Supernatant was removed
by vacuum suction, accompanied by wash with cold DPBS. BCG was infected at
MOI of 1 and cells were incubated for 24hrs, 48hrs, and 72hrs.
93. RESULTS
3.1. Oasl1-/- Bone Marrow Derived Macrophages show
increased mRNA expression of type I IFNs
To explore physiological role of Oasl1 during bacterial secondary messenger
treatment, bone marrows derived macrophages (BMDMs) were prepared from both
Oasl1(+/+ and -/-) mice. Oasl1-/- mice displayed no abnormal phenotypes and
were born at Mendelian ratios. Previously, our lab reported increased production of
type I IFNs in Oasl1-/- mice due to translational inhibition of IRF7 by Oasl1 at 5'
UTR (Lee et al., 2013). mRNA expression of Oasl1 gene was increased in time
dependent manner when treated with c-di-gmp and c-di-amp (Fig. 1a). As
expected, WT and KO mice did not show significant difference in mRNA
expression level of IRF7 (Figure 1a). However, immunoblot assay showed
increased protein expression of IRF7 in Oasl1-/- mice (Figure 1b). IRF7 is a
master regulator of type I IFN production and it regulates induction of IFNs via
Myd88 dependent or independent manner (Honda et al. 2005). Previous report on
Oasl1 KO mice (Lee et al., 2013) showed that Oasl1 KO mice showed increased
protein expression of type I IFNs due to absence of negative regulator of IRF7.
This probably accounts for increased mRNA expression of type I IFNs in Oals1
KO mice during bacterial secondary messengers treatment (Figure 1a). Increased
production of type I IFNs will lead to increased expression of ISGs.
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3.2. Differential mRNA expression of cytokines in Oasl1
WT and KO mice
To investigate difference in cytokine level due to IFNs, mRNA expression of
ISGs were measured by qPCR analysis. First, to consider optimal condition for
treatment, c-di-gmp and c-di-AMP were delivered to cell through lipofectamine
2000 in dose dependent manner. mRNA expression showed that either 5uM or
10uM was optimal for viewing difference between WT and KO mice (Fig. 2c).
Concentration higher than 10uM showed lesser mRNA expression, suggesting that
higher dose may have cytoxic effects on cells. Further analysis with cell
proliferation assay maybe required for understanding why mRNA expression of
each gene decrease with increasing dose. Although c-di-GMP and AMP share
similar structure, their potency to induce type I IFNs may be different, explaining
difference in ISGs expression levels.
mRNA expression of CXCLl10 and IL-10 level were significantly increased in
KO mice at 9hr (Fig. 2a, b). While both genes are known to be induced by type I
IFNs, CXCL10 is more associated with IFNγ. On the other hand, expression of
IL-1β was higher in WT at 3hr. This may indicate pathway independent of type I
IFNs as induction time is too early. It may also suggest different factors
contributing to negative regulation of IL-1β. Other notable cytokines such as IL-6,
CXCL9, and IFIT1 did not show notable difference in mRNA expression. There
may be other mechanism of inhibition that suppress induction by type I IFNs.
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3.3. TNFα expression level does not differ between WT
and KO mice
After observing difference in various ISGs such as IL-10, we sought to
measure difference in amount of protein produced by WT and KO BMM. Mainly
produced by macrophages, TNFα is a protein known for its involvement in
inflammation and regulation of immune cells. They are also important for NF-κB
pathway activation and recruitment of macrophages that can directly suppress
bacterial proliferation. It has been reported that IL-10 can inhibit production of this
pro-inflammatory cytokine (Riley et al., 1999). We performed ELISA assay in
order to see difference in protein level of TNFα.
However, higher mRNA expression of IL-10 in KO mice (Fig 2a,b) did not
down-regulate TNFα as shown by both ELISA and mRNA expression (Fig. 3a,b)
This indicate that other factor maybe working along with IL-10 to suppress
induction of TNFα and NF-κB pathway do not significantly differ in Oasl1 KO
mice compared to that of WT mice.
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3.4. Il-10 level is increased in BCG infected Oasl1 WT
and KO BMDM
Since bacterial infection incorporates various components besides c-di-GMP and
c-di-AMP signaling, we sought to observe how bacteria affects protein expression.
We infected Oasl1 WT and KO mice with BCG accompanied by pre-treatment
with or without poly I:C; TNFα and IL-6 protein level did not differ significantly
among WT and KO mice; However, IL-10 also did not show notable difference
which does not explain our previous mRNA expression data using both types of
nucleotides. Bacterial secondary messenger producing part is well-conserved in
BCG. On the other hand, BCG has mutated Rv1357c region and lacks type VII
secretion system ESX-1 so it may not be a full account for MTB infection. While
MTB can survive inside macrophages and also arrest autophagy-lysosome
pathway, BCG becomes attenuated in macrophages and is cleared by autophagy.
Thus, we would need further studies to understand our type I Interferon level
changes in BMMs when treated with BCG.
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4. DISCUSSION
Indirect effects by type I IFNs during anti-bacterial response by immune cells
were reported by number of journals recently. Furthermore, it was indicated that
type I IFNs may actually down-regulate type II IFN, thereby exacerbating the
condition of patients during mycobacterial infection. The role of interferons during
mycobacterial infection has become especially important as it is known to activate
or deactivate late onset of the disease by unknown mechanism. As a number of
antibiotic-resistant bacteria are growing due to inadequate use by a lay person or
negligence in patient's part, it is essential to discover another way of regulating
bacterial growth.
In this paper, we used Oasl1 KO transgenic mice to uncover role of type I IFNs
during bacterial infection. While IRF7 mRNA expression did not show significant
difference between WT and KO mice, protein blot showed increased expression of
IRF7 in KO mice which can be explain by our previous finding that showed
negative regulation of IRF7 by Oasl1 due to its capability to bind to 5'-UTR
region of IRF7. IRF7 regulates type I IFNs and this leads to increased level of
various ISGs. In our study, we found increase in some of the ISGs in KO mice
but not all of them. This indicate other mechanisms independent of type I IFNs
are regulating induction of certain ISGs. It also suggest unknown function of
Oasl1 gene.
IL-10 and CXCL10 showed increased mRNA transcription in KO mice. IL-10 is
known to negatively regulate TNFα; however, ELISA assay shows no significant
change between WT and KO suggesting other factor working along with IL-10
for regulation. TNFa is especially important for defense against mycobacterial
species as it is known to mediate both resistance and susceptibility of infection.
Roca et al. discovered that excess amount of TNFα can cause necroptosis in
macrophages, there by resulting in release of mycobacteria (Roca and
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Ramarkrishnan L. et al., 2013). Furthermore, TNF is also known to induce NF-κB
pathway which can induce production of nitric oxide synthatase and IL-2. These
factors all contribute to defense against mycobacterial infection but little difference
in either mRNA expression or protein expression between Oasl1 WT and KO mice
suggest that observed differences can be attributed to type I IFNs (Yamada,
Mizuno, Reza-Gholizadeh and Sugawara et al., 2001). Interferon α inhibitors were
pre-treated for BMDMs and TNFα protein level measured; however, little
difference was observed. This may suggest that type I IFNs do not affect
production of TNFα markedly.
CXCL10 is a well-known IFNγ inducible factor (Luster, Unkeless, and Ravetech
et al. 1985). Constitutive expression of c-Jun leads to continuous production of
IFNβ at low level, that results in cell's increased sensitivity for Type I and II
IFNs (Gough et al., 2010). However, recent studies revealed that type I IFNs
negatively regulated IFNγ receptors during mycobacterial infection (Teles et al.,
2013). Furthermore, IL-10, one of ISGs of type I IFNs, inhibited anti-microbial
peptide response by IFNγ induced macrophage. Our data show increased
expression of both IFNβ and IL-10 during bacterial secondary messenger
treatment. It would be worthwhile to observe IFNγ receptor expression and
anti-bacterial response mounted by macrophages in KO mice. As we have seen
from previous studies, Oasl1 transgenic mice might also display increased
susceptibility to mycobacterial infection.
Guarda and his colleagues reported two pathways for negative regulation of
IL-1 production by Type I IFNs (Guarda et al., 2011). First, STAT1 transcription
factor suppressed the inflammasome activity, leading to decreased IL-1β 
maturation. Secondly, increased IL-10 reduced amount of pro-IL-1 forms. Latter
mechanism can explain our data, in which IL-10 level in KO mice was increased
while mRNA expression of IL-1β was decreased. However, in order to confirm
this data, we still need to find out whether Oasl1 KO mice really show decreased
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pro-IL-1 forms compared to WT mice when treated with bacterial secondary
messengers. Furthermore, our qPCR assay showing significant difference between
mRNA expression of IL-10 in WT and KO mice at 9hr that cannot fully explain
increased IL-1β level at 3hr in WT mice. We would also need to explore
inflammasome activity and also STAT transcription in Oasl1 mice.
BCG infection of Oasl1 WT and KO BMDMs leaves much room for discussion
since we could not observe same condition as we had observed when we treated
BMDMs with bacterial secondary messengers. Little difference between WT and
KO mice may be due to difference in c-di-GMP and AMP producing region of
BCG. Furthermore, BCG's inability to arrest autophagy pathway and subsequent
attenuation by macrophages may explain this phenomenon. Further research
incorporating type I IFN protein level in sup. and study with MTB should be
performed.
In conclusion, we found that increased IFN production in Oasl1 transgenic mice
led to differential mRNA expression when treated with bacterial secondary
messengers. Since both type I IFNs and IL-10 is reported to suppress
anti-bacterial activity, increased type I IFNs production in KO mice during
bacterial infection can possibly aggravate the condition. Type I IFN treatment for
patients with autoimmune disease such as Multiple Sclerosis should be considered
carefully as it can make patients more susceptible to bacterial invasion.
16
- Figure 1 Continued
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Figure 1. Increased type I IFN production in Oasl1-/- mice
(A) BMDMs were treated with either c-di-GMP or c-di-AMP using
Lipofectamine 2000. RNA was purifed by using TriZol and was converted to
cDNA. Expression data was measured using GAPDH for normalization. (B)
BMDMs were lysed with RIPA buffer and protein specific antibodies were
attached overnight for development.
18
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Figure 2. Differential cytokine expression in Oasl1 WT vs. KO mice
mRNA expression of cytokines from WT and KO BMDMS were measured
following the same protocol from Figure 1. c-di-GMP treatment (A) and
c-di-AMP treatment (B). Dose dependent treatment of nucleotides were conducted
following the same protocol. Cells were collected at 9hr. (C)
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Figure 3. Comparison of expression level of TNFα in qPCR and ELISA
mRNA expression of TNFα from WT and KO BMDMS were measured using
same method (A). ELISA assay was performed using cell supernatant from
BMDMs. Both types of BMDMs were either pre-treated with or without Interferon
α (B).
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Figure 4. Comparison of protein level of BCG infected WT and KO BMMs
Protein level of supernatant collected from BCG infected Oasl1 BMDM. They were
pre-treated w/o or with poly I:C at 10ug/ml. Measured with ELISA assay
(Biolegend). Two duplicate sets were conducted.
22
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Abstract in Korean
Oasl1 KO 쥐에서 박테리아 2차 전달물질에 의한 세포 반응의 차이
  박테리아 및 바이러스 감염시 인터페론의 역할은 항상 흥미로운 주제였다. 1900년 
초부터 시작된 인터페론에 관한 연구들은 JAK-STAT 기작 그리고 다른 종류의 인터
페론에 대해 밝혀냈다. 하지만 각기 다른 종류의 인터페론들이 어떤 방식으로 서로에
게 영향을 주는지 아직 명확하게 밝혀지지 않았고 또한 박테라아 감염시 타입 I 인터
페론의 역할에 대해서는 상반된 결과가 발표되고 있다.
  c-di-GMP와 c-di-AMP는 박테리아 2차 전달 물질로 생물막 생성 및 박테리아의 
증식에 중요한 역할을 하는 것으로 알려져 있다. 이 물질들은 패턴 인식 수용체 
(PRR)에 의해 인식되며 그로인해 항박테리아 반응이 일어나게 된다. 최근에는 이 뉴
클레오티드들이 STING 기작을 통해 타입 I 인터페론 생성을 일으킨다는 사실이 밝혀
졌다.
  이 실험에서 우리는 병원균 침입시 타입 I 인터페론을 과다생성하는 Oasl1 유전자
변형 쥐를 이용하여 박테리아 감염시 인터페론의 역할에 대해서 밝히고자 하였다. 이
를 위해서 쥐 골수세포를 채취하여 대식세포로 분화시키고 c-di-GMP 및 c-di-AMP
를 처리하여 박테리아 침입 시와 비슷한 환경을 조성하였다.
  우리는 타입 I 인터페론 mRNA가 KO mice에서 더 많이 발현되는 것을 확인하였고 
이는 그 전에 밝혀진 Oasl1의 IRF7 단백질 생성을 저해하기 때문에로 예측된다. 타
입 I 인터페론의 과다 발현으로 인해 몇 몇 개의 ISG들이 더 많이 발현되었으며 이 
들 중에는 IL-10 및 CXCL10이 있었다. IL-10의 경우 결핵균 감염 시 이의 증식을 
                                                                           
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저해하는 단백질의 역할을 막는 것으로 알려져 있다. 타입 I 인터페론의 일종인 인터
페론β 역시 인터페론γ 수용체의 발현을 저해해 전체적으로 항박테리아 기능을 막는 
것으로 알려져있다.
  IL-10은 TNFα 생성에도 영향을 주는 것으로 알려져 있는데 실제 mRNA 발현이나 
단백질 생성에는 WT 및 KO 쥐에서 별 차이가 없는 것으로 보아 IL-10을 제외한 다
른 요소도 같이 작용하는 것으로 보인다. WT 쥐에서 IL-1β mRNA 발현이 더 높은 
것은 KO 쥐에서 IL-10이 전체적으로 더 많이 발현되는 것으로 설명할 수도 있지만 
두 가지의 다른 기작이 존재하기 때문에 추가 실험을 통해 확인해 봐야 할 것이다. 
또한 CXCL10의 경우 IFNγ의 영향을 많이 받기 때문에 이 역시도 다른 실험으로 확
인해 봐야한다.
이 실험을 통해 타입 I 인터페론의 과다 생성은 박테리아 감염 시 숙주에게 좋지
않은 영향을 미칠 수 있다는 것을 밝혀냈다. 자가면역질환 환자들의 경우 타입 I 인터
페론을 처방하기도 하는데 박테리아 감염 시에는 이런 처방을 다시 한 번 고려해보고
사용해야 할 것으로 보인다.
